Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Decreased FoxP3 gene expression in the nasal secretions from patients with allergic rhinitis

Decreased FoxP3 gene expression in the nasal secretions from patients with allergic rhinitis Objective: To determine whether patients with allergic rhinitis have altered FoxP3 gene expression and/or mutations.Study Design and Methods: We collected nasal secretions from 14 volunteers (five of whom have allergic rhinitis) and five ENT allergy patients. Total RNA was isolated from these nasal secretions. The gene expression levels of FoxP3 were quantified by both semi-quantitative RT-PCR and real-time PCR using Actin as a housekeeping gene. The cDNA fragments amplified by RT-PCR were analyzed by DNA sequencing.Results: We found that patients with allergic rhinitis had significantly lower FoxP3 mRNA compared to nonallergic controls (P < 0.01). In addition, we found a point mutation in the FoxP3 gene from a patient who not only has severe allergic rhinitis, but also has asthma. This mutation locates in a highly conserved region of FoxP3 gene and partially impaired FoxP3 functions.Conclusion: Our data indicate that either reduced FoxP3 gene expression or impaired FoxP3 functions are involved in the development of allergic disease in humans. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Otolaryngology: Head and Neck Surgery Wiley

Decreased FoxP3 gene expression in the nasal secretions from patients with allergic rhinitis

Loading next page...
 
/lp/wiley/decreased-foxp3-gene-expression-in-the-nasal-secretions-from-patients-AOX5VV4foe

References (23)

Publisher
Wiley
Copyright
© 2009 SAGE Publications
ISSN
0194-5998
eISSN
1097-6817
DOI
10.1016/j.otohns.2008.08.016
pmid
19201288
Publisher site
See Article on Publisher Site

Abstract

Objective: To determine whether patients with allergic rhinitis have altered FoxP3 gene expression and/or mutations.Study Design and Methods: We collected nasal secretions from 14 volunteers (five of whom have allergic rhinitis) and five ENT allergy patients. Total RNA was isolated from these nasal secretions. The gene expression levels of FoxP3 were quantified by both semi-quantitative RT-PCR and real-time PCR using Actin as a housekeeping gene. The cDNA fragments amplified by RT-PCR were analyzed by DNA sequencing.Results: We found that patients with allergic rhinitis had significantly lower FoxP3 mRNA compared to nonallergic controls (P < 0.01). In addition, we found a point mutation in the FoxP3 gene from a patient who not only has severe allergic rhinitis, but also has asthma. This mutation locates in a highly conserved region of FoxP3 gene and partially impaired FoxP3 functions.Conclusion: Our data indicate that either reduced FoxP3 gene expression or impaired FoxP3 functions are involved in the development of allergic disease in humans.

Journal

Otolaryngology: Head and Neck SurgeryWiley

Published: Feb 1, 2009

There are no references for this article.